Financhill
Sell
41

SINT Quote, Financials, Valuation and Earnings

Last price:
$2.99
Seasonality move :
-19.22%
Day range:
$3.31 - $3.45
52-week range:
$1.71 - $8.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.19x
P/B ratio:
1.37x
Volume:
13.4K
Avg. volume:
44.3K
1-year change:
-39.34%
Market cap:
$8.4M
Revenue:
$1.2M
EPS (TTM):
-$13.12

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SINT
SINTX Technologies
$400K -$0.79 5.82% -78.12% $28.00
IVF
INVO Fertility
$1.7M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies
$1.8M -- 120.4% -57.14% $1.45
NTRB
Nutriband
$665K -$0.17 59.2% -13.33% $15.00
NVNO
enVVeno Medical
-- -$0.28 -- -9.68% $12.50
XAIR
Beyond Air
$1.7M -- 155.97% -- $2.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SINT
SINTX Technologies
$3.33 $28.00 $8.4M -- $0.00 0% 3.19x
IVF
INVO Fertility
$0.78 -- $1.7M -- $0.00 0% 0.07x
NMTC
NeuroOne Medical Technologies
$0.71 $1.45 $35.5M -- $0.00 0% 3.68x
NTRB
Nutriband
$7.96 $15.00 $88.6M -- $0.00 0% 36.83x
NVNO
enVVeno Medical
$4.18 $12.50 $73.3M -- $0.00 0% 407.78x
XAIR
Beyond Air
$0.17 $2.25 $800.8K -- $0.00 0% 63.05x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SINT
SINTX Technologies
2.11% 1.788 1.98% 2.98x
IVF
INVO Fertility
65.97% 1.151 20.29% 0.05x
NMTC
NeuroOne Medical Technologies
-- 0.459 -- 0.93x
NTRB
Nutriband
3.43% 1.334 0.24% 3.31x
NVNO
enVVeno Medical
-- 1.389 -- --
XAIR
Beyond Air
41.93% 0.040 42.16% 1.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SINT
SINTX Technologies
$45K -$2.4M -177.02% -180.99% -783.16% -$1.4M
IVF
INVO Fertility
$592.3K -$2.5M -313.33% -714.24% -1044.01% -$3.6M
NMTC
NeuroOne Medical Technologies
$771.1K -$2.7M -281.01% -281.01% -163.76% -$59.3K
NTRB
Nutriband
$252K -$1.4M -100.04% -102.63% -207.21% -$1.3M
NVNO
enVVeno Medical
-- -$5M -- -- -- -$4M
XAIR
Beyond Air
-$32K -$7.2M -146.65% -218.07% -649.57% -$8.5M

SINTX Technologies vs. Competitors

  • Which has Higher Returns SINT or IVF?

    INVO Fertility has a net margin of -787.63% compared to SINTX Technologies's net margin of -1063.02%. SINTX Technologies's return on equity of -180.99% beat INVO Fertility's return on equity of -714.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
  • What do Analysts Say About SINT or IVF?

    SINTX Technologies has a consensus price target of $28.00, signalling upside risk potential of 740.84%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 673.4%. Given that SINTX Technologies has higher upside potential than INVO Fertility, analysts believe SINTX Technologies is more attractive than INVO Fertility.

    Company Buy Ratings Hold Ratings Sell Ratings
    SINT
    SINTX Technologies
    1 0 0
    IVF
    INVO Fertility
    0 0 0
  • Is SINT or IVF More Risky?

    SINTX Technologies has a beta of 0.713, which suggesting that the stock is 28.749% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.045, suggesting its more volatile than the S&P 500 by 104.471%.

  • Which is a Better Dividend Stock SINT or IVF?

    SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SINT or IVF?

    SINTX Technologies quarterly revenues are $291K, which are smaller than INVO Fertility quarterly revenues of $1.6M. SINTX Technologies's net income of -$2.3M is higher than INVO Fertility's net income of -$17.4M. Notably, SINTX Technologies's price-to-earnings ratio is -- while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 3.19x versus 0.07x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
  • Which has Higher Returns SINT or NMTC?

    NeuroOne Medical Technologies has a net margin of -787.63% compared to SINTX Technologies's net margin of -163.76%. SINTX Technologies's return on equity of -180.99% beat NeuroOne Medical Technologies's return on equity of -281.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
    NMTC
    NeuroOne Medical Technologies
    55.61% -$0.07 $1.1M
  • What do Analysts Say About SINT or NMTC?

    SINTX Technologies has a consensus price target of $28.00, signalling upside risk potential of 740.84%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 103.65%. Given that SINTX Technologies has higher upside potential than NeuroOne Medical Technologies, analysts believe SINTX Technologies is more attractive than NeuroOne Medical Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    SINT
    SINTX Technologies
    1 0 0
    NMTC
    NeuroOne Medical Technologies
    1 0 0
  • Is SINT or NMTC More Risky?

    SINTX Technologies has a beta of 0.713, which suggesting that the stock is 28.749% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.052%.

  • Which is a Better Dividend Stock SINT or NMTC?

    SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SINT or NMTC?

    SINTX Technologies quarterly revenues are $291K, which are smaller than NeuroOne Medical Technologies quarterly revenues of $1.4M. SINTX Technologies's net income of -$2.3M is lower than NeuroOne Medical Technologies's net income of -$2.3M. Notably, SINTX Technologies's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 3.19x versus 3.68x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
    NMTC
    NeuroOne Medical Technologies
    3.68x -- $1.4M -$2.3M
  • Which has Higher Returns SINT or NTRB?

    Nutriband has a net margin of -787.63% compared to SINTX Technologies's net margin of -208.09%. SINTX Technologies's return on equity of -180.99% beat Nutriband's return on equity of -102.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
  • What do Analysts Say About SINT or NTRB?

    SINTX Technologies has a consensus price target of $28.00, signalling upside risk potential of 740.84%. On the other hand Nutriband has an analysts' consensus of $15.00 which suggests that it could grow by 88.44%. Given that SINTX Technologies has higher upside potential than Nutriband, analysts believe SINTX Technologies is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    SINT
    SINTX Technologies
    1 0 0
    NTRB
    Nutriband
    1 0 0
  • Is SINT or NTRB More Risky?

    SINTX Technologies has a beta of 0.713, which suggesting that the stock is 28.749% less volatile than S&P 500. In comparison Nutriband has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.565%.

  • Which is a Better Dividend Stock SINT or NTRB?

    SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SINT or NTRB?

    SINTX Technologies quarterly revenues are $291K, which are smaller than Nutriband quarterly revenues of $667.4K. SINTX Technologies's net income of -$2.3M is lower than Nutriband's net income of -$1.4M. Notably, SINTX Technologies's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 3.19x versus 36.83x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
  • Which has Higher Returns SINT or NVNO?

    enVVeno Medical has a net margin of -787.63% compared to SINTX Technologies's net margin of --. SINTX Technologies's return on equity of -180.99% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
    NVNO
    enVVeno Medical
    -- -$0.22 --
  • What do Analysts Say About SINT or NVNO?

    SINTX Technologies has a consensus price target of $28.00, signalling upside risk potential of 740.84%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 199.04%. Given that SINTX Technologies has higher upside potential than enVVeno Medical, analysts believe SINTX Technologies is more attractive than enVVeno Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    SINT
    SINTX Technologies
    1 0 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is SINT or NVNO More Risky?

    SINTX Technologies has a beta of 0.713, which suggesting that the stock is 28.749% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.932, suggesting its less volatile than the S&P 500 by 6.781%.

  • Which is a Better Dividend Stock SINT or NVNO?

    SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SINT or NVNO?

    SINTX Technologies quarterly revenues are $291K, which are larger than enVVeno Medical quarterly revenues of --. SINTX Technologies's net income of -$2.3M is higher than enVVeno Medical's net income of -$4.5M. Notably, SINTX Technologies's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 3.19x versus 407.78x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
    NVNO
    enVVeno Medical
    407.78x -- -- -$4.5M
  • Which has Higher Returns SINT or XAIR?

    Beyond Air has a net margin of -787.63% compared to SINTX Technologies's net margin of -697.4%. SINTX Technologies's return on equity of -180.99% beat Beyond Air's return on equity of -218.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
    XAIR
    Beyond Air
    -2.78% -$0.09 $24.1M
  • What do Analysts Say About SINT or XAIR?

    SINTX Technologies has a consensus price target of $28.00, signalling upside risk potential of 740.84%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 25971.84%. Given that Beyond Air has higher upside potential than SINTX Technologies, analysts believe Beyond Air is more attractive than SINTX Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    SINT
    SINTX Technologies
    1 0 0
    XAIR
    Beyond Air
    2 1 0
  • Is SINT or XAIR More Risky?

    SINTX Technologies has a beta of 0.713, which suggesting that the stock is 28.749% less volatile than S&P 500. In comparison Beyond Air has a beta of 0.221, suggesting its less volatile than the S&P 500 by 77.879%.

  • Which is a Better Dividend Stock SINT or XAIR?

    SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SINT or XAIR?

    SINTX Technologies quarterly revenues are $291K, which are smaller than Beyond Air quarterly revenues of $1.2M. SINTX Technologies's net income of -$2.3M is higher than Beyond Air's net income of -$8M. Notably, SINTX Technologies's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 3.19x versus 63.05x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
    XAIR
    Beyond Air
    63.05x -- $1.2M -$8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock